Skip to main content

SB 987 — Maryland

Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 987 is a bill in the Maryland Senate, 2026 session, introduced February 15, 2026.
  • Sponsored by Lewis Young.
  • Current status: introduced.
  • Most recent action (March 5, 2026): Hearing 3/11 at 1:00 p.m.
  • Subjects: Advertising, Comptroller, Corporations, Digital Images, Drugs, Electronic Communication.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Lewis Young

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House of Delegates, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate First Reading Senate Rules
  2. Senate Rereferred to Budget and Taxation
  3. Senate Hearing 3/11 at 1:00 p.m. Latest

Source: Open States. Last checked November 7, 2026. How we keep this accurate ›